Ledger.Open graph →
SEC Form D · Amendment · filed April 27, 2017

Inspyr Therapeutics, Inc

Offering
$300K
Sold
$290K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WESTLAKE VILLAGE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Claire J. Thom · Westlake Village, CADirectorPeter J. Grebow · Westlake Village, CADirectorChristopher Lowe · Westlake Village, CAExec · DirectorRonald Shazer · Westlake Village, CAExecRichard J. Buller · Westlake Village, CADirectorScott J. Ogilvie · Westlake Village, CADirectorBo J. Hansen · Westlake Village, CADirectorEric Baum · Santa Ana, CADirectorBarbara Goodstein · Santa Ana, CAExec · DirectorWasim Rehman · GEORGE TOWN, GRAND CAYMAN, Cayman IslandsExecMark D. Savit · Centennial, CODirectorPaul A. Lythberg · Chicago, ILDirectorJohn D. Hay · Centennial, CODirectorRobert L. Marsh · PITTSBURGH, PADirectorJoshua D. Savit · Centennial, CODirectorCarol D. Setters · Centennial, COExec · DirectorHenry D. Bowles · Centennial, CODirectorMark D. Premo · Centennial, CODirectorTimothy D. Hobbs · Centennial, CODirectorKenneth S. Tapp · Denver, CODirectorKevin C. Suther · KIRKLAND, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗